中文
| Catalogue |
|
|
| Recommend Products |
Topas Therapeutics GmbH
Germany, Manufacturer, Hits: 1013, Updated:8/22/2017
Falkenried 88, Haus A,20251 Hamburg |
Company Profile
-
Topas Therapeutics is a Hamburg/Germany based biotech company that develops products to restore or induce antigen-specific tolerance. The underlying invention was made at the University of Hamburg (Prof. Dr. Johannes Herkel et al.).
Topas Therapeutics was founded in 2013 by entrepreneurs and by Bionamics, an asset management company that was acquired by Evotec in spring 2014. In March 2016 a Series A financing was concluded that provided Topas Therapeutics with € 14 Mio through investments of Epidarex Capital (Lead), Evotec (Co-Lead), EMBL Ventures and Gimv.
In 2016, Topas moved its offices and laboratories to the Center of Innovative Medicines (CIM) in Hamburg, next to the campus of the University Medical Center Hamburg-Eppendorf (UKE).
Company News
- Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer 10/20/2020
- Topas Therapeutics to Participate at Upcoming Industry and Scientific Events 9/28/2018
- Topas Therapeutics and Boehringer Ingelheim Sign an Agreement 4/24/2018
- Topas Therapeutics Appoints Rupert Sandbrink as Chief Officer 10/27/2017
- Topas Therapeutics signs agreement with Lilly focused on immune tolerance 8/22/2017